Tetraspanin in oncogenic epithelial-mesenchymal transition

Journal of Clinical Investigation

Volumn 118, Issue 4, 2008, Pages 1347-1350

  Muschel, Ruth J ^a   Gal, Annamaria ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN TM4SF5; TETRASPANIN; UNCLASSIFIED DRUG;

CANCER GROWTH; CARCINOGENESIS; CARCINOGENIC ACTIVITY; EPITHELIUM CELL; HUMAN; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; MESENCHYME CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; EPITHELIAL CELLS; HUMANS; MEMBRANE PROTEINS; MESODERM; MICE; MODELS, BIOLOGICAL;

EID: 41849086329     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI35308     Document Type: Note

References (24)

1. Gress, T.M., et al. 1997. Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis. Genes Chromosomes Cancer. 19:97-103.
2. Muller-Pillasch, F., et al. 1998. Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene. 208:25-30.
3. Wright, M.D., Ni, J., and Rudy, G.B. 2000. The L6 membrane proteins - a new four-transmembrane superfamily. Protein Sci. 9:1594-1600.
4. Chang, Y.W., et al. 2005. CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int. J. Cancer. 116:243-252.
5. Lazo, P. 2007. Functional implications of tetraspanin proteins in cancer biology. Cancer Sci. 98:1666-1677.
6. Hay, E.D. 1995. An overview of epithelio-mesenchymal transformations. Acta Anat. 154:8-20.
7. Kiemer, A.K., Takeuchi, K., and Quinlan, M.P. 2001. Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene. 20:6679-6688
8. Janda, E., et al. 2002. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156:299-313.
9. Vincent-Salomon, A., and Thiery, J.P. 2003. Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res. 5:101-106.
10. Xue, C., Plieth, D., Venkov, C., Xu, C., and Neilson, E.G. 2003. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastases. Cancer Res. 63:3386-3394.
11. Hemler, M.E. 2005. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 6:801-811.
12. Lammerding, J., Kazarov, A.R., Huang, H., Lee, R.T., and Hemler, M.E. 2003. Tetraspanin CD151 regulates alpha6beta1 integrin adhesion strengthening. Proc. Natl. Acad. Sci. U. S. A. 100:7616-7621.
13. Garcia-Lopez, M.A., et al. 2005. Role of tetraspanins CD9 and CD151 in primary melanocyte motility. J. Invest. Dermatol. 125:1001-1009.
14. Testa, J.E., Brooks, P.C., Lin, J.M., and Quigley, J.P. 1999. Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res. 59:3812-3820.
15. Lee, S.-A., et al. 2008. Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelialmesenchymal transition in human hepatocarcinoma. J. Clin. Invest. 118:1354-1366.
16. Lee, S.Y., et al. 2006. Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin alpha2 are regulated by serum treatment. Exp. Cell Res. 312:2983-2999.
17. Gal, A., et al. 2008. Sustained TGFbeta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene. 27:1218-1230.
18. Gotzmann, J., et al. 2004. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat. Res. 566:9-20.
19. Kaimori, A., et al. 2007. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 282:22089-22101.
20. Gotzmann, J., et al. 2002. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J. Cell Sci. 115:1189-1202.
21. Huber, M.A., Kraut, N., and Beug, H. 2005. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17:548-558.
22. Moustakas, A., and Heldin, C.H. 2007. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98:1512-1520.
23. Bakin, A.V., Tomlinson, A.K., Bhowmick, N.A., Moses, H.L., and Arteaga, C.L. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275:36803-36810.
24. Yang, Y., et al. 2006. Regulation of transforming growth factor-β1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. Cancer Res. 66:8617-8624.